{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:06:54Z","timestamp":1759032414330,"version":"3.37.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,7]],"date-time":"2019-12-07T00:00:00Z","timestamp":1575676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,7]],"date-time":"2019-12-07T00:00:00Z","timestamp":1575676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"crossref","award":["2U54GM104942-02"],"award-info":[{"award-number":["2U54GM104942-02"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychiatr Q"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s11126-019-09693-6","type":"journal-article","created":{"date-parts":[[2019,12,7]],"date-time":"2019-12-07T00:07:02Z","timestamp":1575677222000},"page":"209-221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prescription Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Depression among Adults with Inflammatory Chronic Conditions in the United States"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4184-1610","authenticated-orcid":false,"given":"Nazneen Fatima","family":"Shaikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8311-1360","authenticated-orcid":false,"given":"Usha","family":"Sambamoorthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,7]]},"reference":[{"issue":"1","key":"9693_CR1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16(1):22\u201334.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"9693_CR2","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/0269881117711708","volume":"31","author":"P Kopschina Feltes","year":"2017","unstructured":"Kopschina Feltes P, Doorduin J, Klein HC, Ju\u00e1rez-Orozco LE, Dierckx RA, Moriguchi-Jeckel CM, et al. Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy. J Psychopharmacol. 2017;31(9):1149\u201365.","journal-title":"J Psychopharmacol"},{"issue":"4","key":"9693_CR3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0306-9877(91)90272-Z","volume":"35","author":"RS Smith","year":"1991","unstructured":"Smith RS. The macrophage theory of depression. Med Hypotheses. 1991;35(4):298\u2013306.","journal-title":"Med Hypotheses"},{"issue":"7","key":"9693_CR4","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2174\/1570159X14666151208113700","volume":"14","author":"O Kohler","year":"2016","unstructured":"Kohler O, Krogh J, Mors O, Eriksen Benros M. Inflammation in depression and the potential for anti-inflammatory treatment. Curr Neuropharmacol. 2016;14(7):732\u201342.","journal-title":"Curr Neuropharmacol"},{"issue":"9","key":"9693_CR5","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732\u201341.","journal-title":"Biol Psychiatry"},{"issue":"9","key":"9693_CR6","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/gps.4250","volume":"30","author":"B Au","year":"2015","unstructured":"Au B, Smith KJ, Gari\u00e9py G, Schmitz N. The longitudinal associations between C-reactive protein and depressive symptoms: evidence from the English longitudinal study of ageing (ELSA). Int J Geriatr Psychiatry. 2015;30(9):976\u201384.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"03","key":"9693_CR7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1017\/S0033291708003723","volume":"39","author":"D Gimeno","year":"2009","unstructured":"Gimeno D, et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med. 2009;39(03):413.","journal-title":"Psychol Med"},{"key":"9693_CR8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.psyneuen.2014.03.019","volume":"45","author":"J Dahl","year":"2014","unstructured":"Dahl J, Ormstad H, Aass HC, Malt UF, Bendz LT, Sandvik L, et al. The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery. Psychoneuroendocrinology. Jul. 2014;45:77\u201386.","journal-title":"Psychoneuroendocrinology"},{"issue":"11","key":"9693_CR9","doi-asserted-by":"crossref","first-page":"1017.e11","DOI":"10.1016\/j.amjmed.2013.02.037","volume":"126","author":"RL Iyengar","year":"2013","unstructured":"Iyengar RL, et al. NSAIDs are associated with lower depression scores in patients with osteoarthritis. Am J Med. 2013;126(11):1017.e11\u20138.","journal-title":"Am J Med"},{"issue":"12","key":"9693_CR10","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","volume":"71","author":"O K\u00f6hler","year":"2014","unstructured":"K\u00f6hler O, et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiat. 2014;71(12):1381\u201391.","journal-title":"JAMA Psychiat"},{"issue":"6","key":"9693_CR11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/JGP.0b013e318227f4da","volume":"20","author":"C Fields","year":"2012","unstructured":"Fields C, Drye L, Vaidya V, Lyketsos C. Celecoxib or naproxen treatment does not benefit depressive symptoms in persons age 70 and older: findings from a randomized controlled trial. Am J Geriatr Psychiatry. 2012;20(6):505\u201313.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"10","key":"9693_CR12","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1176\/appi.ajp.2012.11091325","volume":"169","author":"PJ Gallagher","year":"2012","unstructured":"Gallagher PJ, Castro V, Fava M, Weilburg JB, Murphy SN, Gainer VS, et al. Antidepressant response in patients with major depression exposed to NSAIDs: a pharmacovigilance study. Am J Psychiatry. 2012;169(10):1065\u201372.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"9693_CR13","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jaad.2009.07.022","volume":"62","author":"A Menter","year":"2010","unstructured":"Menter A, et al. The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial. J Am Acad Dermatol. 2010;62(5):812\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"9693_CR14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1176\/ajp.152.2.265","volume":"152","author":"GW Arana","year":"1995","unstructured":"Arana GW, Santos AB, Laraia MT, McLeod-Bryant S, Beale MD, Rames LJ, et al. Dexamethasone for the treatment of depression: a randomized, placebo- controlled, double-blind trial. Am J Psychiatry. Feb. 1995;152(2):265\u20137.","journal-title":"Am J Psychiatry"},{"key":"9693_CR15","unstructured":"K. Park, Park\u2019s textbook of preventive and social medicine-Banarsidas Bhanot | Ayurveda | Medicine. 2015."},{"key":"9693_CR16","unstructured":"Medical Expenditure Panel Survey Public Use File, 2015. [Online]. Available: https:\/\/meps.ahrq.gov\/mepsweb\/data_stats\/download_data_files_results.jsp?cboDataYear=2015&buttonYearandDataType=Search. (Accessed 08 Aug 2018)."},{"key":"9693_CR17","unstructured":"Medical Expenditure Panel Survey, Understanding and Analyzing MEPS Household Component Medical Condition Data, 2018. [Online]. Available: https:\/\/meps.ahrq.gov\/survey_comp\/MEPS_condition_data.shtml. (Accessed 24 Apr 2018)."},{"key":"9693_CR18","unstructured":"Medical Expenditure Panel Survey Public Use File Details | 2015 Medical Conditions File, 2017. [Online]. Available: https:\/\/meps.ahrq.gov\/mepsweb\/data_stats\/download_data_files_detail.jsp?cboPufNumber=HC-180. (Accessed 08 Aug 2018)."},{"key":"9693_CR19","unstructured":"Medical Expenditure Panel Survey Public Use File Details | 2015 Prescribed Medicines File, 2017. [Online]. Available: https:\/\/meps.ahrq.gov\/mepsweb\/data_stats\/download_data_files_detail.jsp?cboPufNumber=HC-178A. (Accessed 08 Aug 2018)."},{"key":"9693_CR20","unstructured":"Agency for Healthcare Research and Quality MEPS HC-178A 2015 Prescribed Medicines, 2017. [Online]. Available: https:\/\/meps.ahrq.gov\/data_stats\/download_data\/pufs\/h178a\/h178adoc.shtml. (Accessed 04 Aug 2018)."},{"issue":"2","key":"9693_CR21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2147\/CIA.S2468","volume":"3","author":"RL Bushardt","year":"2008","unstructured":"Bushardt RL, Massey EB, Simpson TW, Ariail JC, Simpson KN. Polypharmacy: misleading, but manageable. Clin Interv Aging. 2008;3(2):383\u20139.","journal-title":"Clin Interv Aging"},{"key":"9693_CR22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-244X-14-10","volume":"14","author":"R Bhattacharya","year":"2014","unstructured":"Bhattacharya R, Shen C, Sambamoorthi U. Excess risk of chronic physical conditions associated with depression and anxiety. BMC Psychiatry. 2014;14:10.","journal-title":"BMC Psychiatry"},{"issue":"6","key":"9693_CR23","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2337\/diacare.24.6.1069","volume":"24","author":"RJ Anderson","year":"2001","unstructured":"Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. Jun. 2001;24(6):1069\u201378.","journal-title":"Diabetes Care"},{"key":"9693_CR24","unstructured":"CDC, Mental Health and Chronic Diseases CDC Fact Sheet, 2012."},{"issue":"1","key":"9693_CR25","doi-asserted-by":"crossref","first-page":"e000550","DOI":"10.1136\/openhrt-2016-000550","volume":"4","author":"JS Davis","year":"2017","unstructured":"Davis JS, et al. Use of non-steroidal anti-inflammatory drugs in US adults: changes over time and by demographic. Open Hear. 2017;4(1):e000550.","journal-title":"Open Hear"},{"key":"9693_CR26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pnpbp.2014.10.003","volume":"57","author":"HA Eyre","year":"2015","unstructured":"Eyre HA, Air T, Proctor S, Rositano S, Baune BT. A critical review of the efficacy of non-steroidal anti-inflammatory drugs in depression. Prog Neuro-Psychopharmacol Biol Psychiatr. 2015;57:11\u20136.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatr"},{"issue":"5","key":"9693_CR27","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1532-5415.2010.02827.x","volume":"58","author":"OP Almeida","year":"2010","unstructured":"Almeida OP, Alfonso H, Jamrozik K, Hankey GJ, Flicker L. Aspirin use, depression, and cognitive impairment in later life: the health in men study. J Am Geriatr Soc. 2010;58(5):990\u20132.","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"9693_CR28","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/da.20589","volume":"26","author":"S Akhondzadeh","year":"2009","unstructured":"Akhondzadeh S, Jafari S, Raisi F, Nasehi AA, Ghoreishi A, Salehi B, et al. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety. 2009;26(7):607\u201311.","journal-title":"Depress Anxiety"},{"issue":"2\u20133","key":"9693_CR29","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jad.2012.03.033","volume":"141","author":"S-H Abbasi","year":"2012","unstructured":"Abbasi S-H, Hosseini F, Modabbernia A, Ashrafi M, Akhondzadeh S. Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study. J Affect Disord. 2012;141(2\u20133):308\u201314.","journal-title":"J Affect Disord"},{"issue":"2","key":"9693_CR30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1515\/REVNEURO.2004.15.2.109","volume":"15","author":"E Pretorius","year":"2004","unstructured":"Pretorius E. Corticosteroids, depression and the role of serotonin. Rev Neurosci. 2004;15(2):109\u201316.","journal-title":"Rev Neurosci"},{"key":"9693_CR31","doi-asserted-by":"crossref","first-page":"170167","DOI":"10.1038\/sdata.2017.167","volume":"4","author":"KJ Quinn","year":"2017","unstructured":"Quinn KJ, Shah NH. A dataset quantifying polypharmacy in the United States. Sci Data. 2017;4:170167.","journal-title":"Sci Data"},{"key":"9693_CR32","doi-asserted-by":"crossref","unstructured":"Gu Q, Dillon CF, Burt VL. Prescription drug use continues to increase: U.S. prescription drug data for 2007\u20132008. NCHS Data Brief. 2010;(42):1\u20138.","DOI":"10.1037\/e665492010-001"},{"issue":"3","key":"9693_CR33","doi-asserted-by":"crossref","first-page":"e0118991","DOI":"10.1371\/journal.pone.0118991","volume":"10","author":"JJ Sutherland","year":"2015","unstructured":"Sutherland JJ, Daly TM, Liu X, Goldstein K, Johnston JA, Ryan TP. Co-Prescription Trends in a Large Cohort of Subjects Predict Substantial Drug-Drug Interactions. PLoS One. 2015;10(3):e0118991.","journal-title":"PLoS One"},{"issue":"22","key":"9693_CR34","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1001\/jama.2018.6741","volume":"319","author":"DM Qato","year":"2018","unstructured":"Qato DM, Ozenberger K, Olfson M. Prevalence of Prescription Medications With Depression as a Potential Adverse Effect Among Adults in the United States. JAMA. 2018;319(22):2289.","journal-title":"JAMA"},{"issue":"1\u20132","key":"9693_CR35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jad.2008.11.016","volume":"117","author":"A Glezer","year":"2009","unstructured":"Glezer A, Byatt N, Cook R, Rothschild AJ. Polypharmacy prevalence rates in the treatment of unipolar depression in an outpatient clinic. J Affect Disord. 2009;117(1\u20132):18\u201323.","journal-title":"J Affect Disord"},{"issue":"2","key":"9693_CR36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.31887\/DCNS.2003.5.2\/rcasagrandetango","volume":"5","author":"R Casagrande Tango","year":"2003","unstructured":"Casagrande Tango R. Psychiatric side effects of medications prescribed in internal medicine. Dialogues Clin Neurosci. 2003;5(2):155\u201365.","journal-title":"Dialogues Clin Neurosci"},{"issue":"5","key":"9693_CR37","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/FJC.0b013e318157f72d","volume":"50","author":"CD Funk","year":"2007","unstructured":"Funk CD, FitzGerald GA. COX-2 inhibitors and cardiovascular risk. J Cardiovasc Pharmacol. 2007;50(5):470\u20139.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"9693_CR38","doi-asserted-by":"crossref","first-page":"e54309","DOI":"10.1371\/journal.pone.0054309","volume":"8","author":"A-M Schjerning Olsen","year":"2013","unstructured":"Schjerning Olsen A-M, et al. Cause-Specific Cardiovascular Risk Associated with Nonsteroidal Anti-Inflammatory Drugs among Myocardial Infarction Patients - A Nationwide Study. PLoS One. 2013;8(1):e54309.","journal-title":"PLoS One"},{"issue":"7553","key":"9693_CR39","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","volume":"332","author":"PM Kearney","year":"2006","unstructured":"Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ. 2006;332(7553):1302\u20138.","journal-title":"BMJ"},{"issue":"1","key":"9693_CR40","doi-asserted-by":"crossref","first-page":"e009074","DOI":"10.1136\/bmjopen-2015-009074","volume":"6","author":"HC Gorton","year":"2016","unstructured":"Gorton HC, Webb RT, Kapur N, Ashcroft DM. Non-psychotropic medication and risk of suicide or attempted suicide: a systematic review. BMJ Open. 2016;6(1):e009074.","journal-title":"BMJ Open"},{"issue":"2","key":"9693_CR41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.japh.2015.12.011","volume":"56","author":"JE Lavigne","year":"2016","unstructured":"Lavigne JE. Suicidal ideation and behavior as adverse events of prescribed medications: an update for pharmacists. J Am Pharm Assoc. 2016;56(2):203\u20136.","journal-title":"J Am Pharm Assoc"},{"issue":"5","key":"9693_CR42","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/HYPERTENSIONAHA.116.08188","volume":"68","author":"AH Boal","year":"2016","unstructured":"Boal AH, Smith DJ, McCallum L, Muir S, Touyz RM, Dominiczak AF, et al. Monotherapy with major antihypertensive drug classes and risk of hospital admissions for mood DisordersNovelty and significance. Hypertension. 2016;68(5):1132\u20138.","journal-title":"Hypertension"},{"issue":"1","key":"9693_CR43","first-page":"17","volume":"22","author":"HJ Aubin","year":"1996","unstructured":"Aubin HJ, Tilikete S, Barrucand D. Depression and smoking. Encephale. 1996;22(1):17\u201322.","journal-title":"Encephale."},{"issue":"2","key":"9693_CR44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/1471-6402.00090","volume":"27","author":"D Belle","year":"2003","unstructured":"Belle D, Doucet J. Poverty, inequality, and discrimination as sources of depression among U.S. women. Psychol Women Q. 2003;27(2):101\u201313.","journal-title":"Psychol Women Q"},{"issue":"12","key":"9693_CR45","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1046\/j.1532-5415.2003.51555.x","volume":"51","author":"S Crystal","year":"2003","unstructured":"Crystal S, Sambamoorthi U, Walkup JT, Akincigil A. Diagnosis and treatment of depression in the elderly Medicare population: predictors, disparities, and trends. J Am Geriatr Soc. Dec. 2003;51(12):1718\u201328.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"9693_CR46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1037\/0003-066X.52.1.25","volume":"52","author":"FM Culbertson","year":"1997","unstructured":"Culbertson FM. Depression and gender: an international review. Am Psychol. 1997;52(1):25\u201331.","journal-title":"Am Psychol"},{"issue":"2","key":"9693_CR47","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/bjsm.35.2.114","volume":"35","author":"F Dimeo","year":"2001","unstructured":"Dimeo F, Bauer M, Varahram I, Proest G, Halter U. Benefits from aerobic exercise in patients with major depression: a pilot study. Br J Sports Med. Apr. 2001;35(2):114\u20137.","journal-title":"Br J Sports Med"},{"issue":"12","key":"9693_CR48","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jama.1990.03450120058029","volume":"264","author":"AH Glassman","year":"1990","unstructured":"Glassman AH, et al. Smoking, Smoking Cessation, and Major Depression. JAMA. 1990;264(12):1546.","journal-title":"JAMA"},{"key":"9693_CR49","unstructured":"NIMH| Major Depression | National Institute of Mental Health. [Online]. Available: https:\/\/www.nimh.nih.gov\/health\/statistics\/major-depression.shtml. (Accessed 03 May 2018)."},{"issue":"2","key":"9693_CR50","first-page":"110","volume":"31","author":"HA O\u2019Neal","year":"2000","unstructured":"O\u2019Neal HA, Dunn AL, Martinsen. Depression and exercise. Int J Sport Psychol. 2000;31(2):110\u201335.","journal-title":"Int J Sport Psychol"},{"issue":"20","key":"9693_CR51","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/archinte.163.20.2433","volume":"163","author":"MJ Bair","year":"2003","unstructured":"Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and Pain Comorbidity: A literature review. Arch Intern Med. 2003;163(20):2433.","journal-title":"Arch Intern Med"}],"container-title":["Psychiatric Quarterly"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-019-09693-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11126-019-09693-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-019-09693-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,6]],"date-time":"2020-12-06T00:33:03Z","timestamp":1607214783000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11126-019-09693-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,7]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["9693"],"URL":"https:\/\/doi.org\/10.1007\/s11126-019-09693-6","relation":{},"ISSN":["0033-2720","1573-6709"],"issn-type":[{"type":"print","value":"0033-2720"},{"type":"electronic","value":"1573-6709"}],"subject":[],"published":{"date-parts":[[2019,12,7]]},"assertion":[{"value":"7 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The opinions expressed in this article are of the authors and do not reflect the views\/opinions of any organization. Ms. Nazneen Fatima Shaikh declares that she has no conflict of interest. Dr. Usha Sambamoorthi has received grant from National Institute of General Medical Sciences of the National Institutes of Health [Award Number 2U54GM104942\u201302], WVCTSI.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The authors disclose that they have no significant relationships with or financial interests in any commercial companies related to this study or article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}